ShareValue.ai

ShareValue scores for CCEL: Valuation 38, Quality 74, Growth 39, Health 37.

CCEL
NYSE American

CryoCell International Inc

$2.90(-24.48%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-8% to 9%
Valuation
38
Overvalued
Price vs Value
Quality
74
Strong
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
37
Stressed
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026